Bradley Herring
CIK 1813901 · EVP & CFO · last filed 2026-05-28
Bradley Herring is an EVP & CFO who has filed 23 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for OPLN, was dated May 28, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.11M
4
23
-$1.14M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OPLN | EVP & CFO | 16,190 | $37.83 | $612.5K | $0 | 2 | 2026-05-28 |
| OPENLANE, Inc. (KAR) Delisted | EVP & CFO | — | $30.88 | — | $0 | 1 | 2025-05-28 |
| Enfusion, Inc. (ENFN) Delisted | Chief Financial Officer | 216,357 | $10.76 | $2.33M | -$408.8K | 10 | 2025-04-21 |
| FOUR | CFO | 60,722 | $41.18 | $2.50M | -$732.0K | 10 | 2022-06-10 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-28 | OPLN | Mixed | +11,737 | -$164.3K | EDGAR |
| 2026-02-20 | OPLN | Grant (A) | — | $0 | EDGAR |
| 2025-05-28 | OPENLANE, Inc. (KAR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-04-21 | Enfusion, Inc. (ENFN) Delisted | Disp (D) | −324,689 | $0 | EDGAR |
| 2025-03-07 | Enfusion, Inc. (ENFN) Delisted | Sell (S) | −4,645 | -$52.8K | EDGAR |
| 2025-03-05 | Enfusion, Inc. (ENFN) Delisted | Sell (S) | −1,533 | -$17.6K | EDGAR |
| 2025-02-28 | Enfusion, Inc. (ENFN) Delisted | Grant (A) | +64,498 | $0 | EDGAR |
| 2025-01-10 | Enfusion, Inc. (ENFN) Delisted | Sell (S) | −4,134 | -$41.9K | EDGAR |
| 2024-12-26 | Enfusion, Inc. (ENFN) Delisted | Sell (S) | −24,443 | -$259.3K | EDGAR |
| 2024-03-05 | Enfusion, Inc. (ENFN) Delisted | Mixed | +83,346 | $62.6K | EDGAR |